Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Clinical Subtype | Transcriptional Subtype | Small Molecule | Antibody | Perturbagen Target | Perturbagen Class | Perturbagen Concentration | Perturbagen Conc Unit | Biological Replicate ID | Relative Cell Count | Normalized Growth Rate Inhibition Value | Nominal Division Rate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CAMA-1 | HR+ | Luminal | Bortezomib | Proteasome | Proteasome | 0.0107 | uM | 5912.074 | 1.0206 | 1.0446 | 0.9249 | |
| CAMA-1 | HR+ | Luminal | Bortezomib | Proteasome | Proteasome | 0.0533 | uM | 5912.074 | 0.8869 | 0.7565 | 0.9249 | |
| CAMA-1 | HR+ | Luminal | Bortezomib | Proteasome | Proteasome | 0.0533 | uM | 5912.074 | 0.8869 | 0.7565 | 0.9249 | |
| CAMA-1 | HR+ | Luminal | Bortezomib | Proteasome | Proteasome | 0.267 | uM | 5912.074 | 0.1254 | -0.7881 | 0.9249 | |
| CAMA-1 | HR+ | Luminal | Bortezomib | Proteasome | Proteasome | 0.267 | uM | 5912.074 | 0.1254 | -0.7881 | 0.9249 | |
| CAMA-1 | HR+ | Luminal | Bortezomib | Proteasome | Proteasome | 1.33 | uM | 5912.074 | 0.0503 | -0.9211 | 0.9249 | |
| CAMA-1 | HR+ | Luminal | Bortezomib | Proteasome | Proteasome | 1.33 | uM | 5912.074 | 0.0503 | -0.9211 | 0.9249 | |
| CAMA-1 | HR+ | Luminal | Bortezomib | Proteasome | Proteasome | 6.67 | uM | 5912.074 | 0.0342 | -0.9479 | 0.9249 | |
| CAMA-1 | HR+ | Luminal | Bortezomib | Proteasome | Proteasome | 6.67 | uM | 5912.074 | 0.0342 | -0.9479 | 0.9249 | |
| CAMA-1 | HR+ | Luminal | Bortezomib | Proteasome | Proteasome | 33.3 | uM | 5912.074 | 0.0162 | -0.9768 | 0.9249 | |
| CAMA-1 | HR+ | Luminal | Bortezomib | Proteasome | Proteasome | 33.3 | uM | 5912.074 | 0.0162 | -0.9768 | 0.9249 | |
| CAMA-1 | HR+ | Luminal | Bortezomib | Proteasome | Proteasome | 167 | uM | 5912.074 | 0.0126 | -0.9824 | 0.9249 | |
| CAMA-1 | HR+ | Luminal | Bortezomib | Proteasome | Proteasome | 167 | uM | 5912.074 | 0.0126 | -0.9824 | 0.9249 | |
| CAMA-1 | HR+ | Luminal | Bortezomib | Proteasome | Proteasome | 0.000171 | uM | 14897.203 | 0.9703 | 0.9372 | 0.9464 | |
| CAMA-1 | HR+ | Luminal | Bortezomib | Proteasome | Proteasome | 0.000171 | uM | 14897.203 | 0.9703 | 0.9372 | 0.9464 | |
| CAMA-1 | HR+ | Luminal | Bortezomib | Proteasome | Proteasome | 0.000853 | uM | 14897.203 | 0.9761 | 0.9496 | 0.9464 | |
| CAMA-1 | HR+ | Luminal | Bortezomib | Proteasome | Proteasome | 0.000853 | uM | 14897.203 | 0.9761 | 0.9496 | 0.9464 | |
| CAMA-1 | HR+ | Luminal | Bortezomib | Proteasome | Proteasome | 0.00427 | uM | 14897.203 | 0.9127 | 0.8161 | 0.9464 | |
| CAMA-1 | HR+ | Luminal | Bortezomib | Proteasome | Proteasome | 0.00427 | uM | 14897.203 | 0.9127 | 0.8161 | 0.9464 | |
| CAMA-1 | HR+ | Luminal | Bortezomib | Proteasome | Proteasome | 0.0213 | uM | 14897.203 | 0.2583 | -0.5215 | 0.9464 | |
| CAMA-1 | HR+ | Luminal | Bortezomib | Proteasome | Proteasome | 0.0213 | uM | 14897.203 | 0.2583 | -0.5215 | 0.9464 | |
| CAMA-1 | HR+ | Luminal | Bortezomib | Proteasome | Proteasome | 0.107 | uM | 14897.203 | 0.0574 | -0.9024 | 0.9464 | |
| CAMA-1 | HR+ | Luminal | Bortezomib | Proteasome | Proteasome | 0.107 | uM | 14897.203 | 0.0574 | -0.9024 | 0.9464 | |
| CAMA-1 | HR+ | Luminal | Bortezomib | Proteasome | Proteasome | 0.533 | uM | 14897.203 | 0.0591 | -0.8994 | 0.9464 | |
| CAMA-1 | HR+ | Luminal | Bortezomib | Proteasome | Proteasome | 0.533 | uM | 14897.203 | 0.0591 | -0.8994 | 0.9464 |